{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:35:54Z","timestamp":1783355754826,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Polish Ministry of Science & Higher Education, Polish Mother\u2019s Memorial Hospital \u2013 Research Institute - Internal Grant","award":["2015\/III\/27-SZB"],"award-info":[{"award-number":["2015\/III\/27-SZB"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibroblast growth factor 19 (FGF19), fibroblast growth factor 21 (FGF21) and Klotho are regulators of energy homeostasis. However, in the pediatric population, the relationships between obesity, metabolic disorders and the aforementioned factors have not been clearly investigated. We analyzed the role of FGF19, FGF21 and Klotho protein in children with normal body weight as well as in overweight and obese subjects and explored their associations with insulin resistance (IR) and metabolic syndrome (MS) and its components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study conducted in a group of hospitalized children and adolescents. Laboratory investigations included serum analysis of FGF19, FGF21, and Klotho with ELISA kits as well as the analysis of the lipid profile and ALT serum concentrations. Moreover, each subject underwent an oral glucose tolerance test (OGTT) with fasting insulinemia measurement to detect glucose tolerance abnormalities and calculate the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index. Furthermore, the clinical analysis included blood pressure measurement, body fat percentage estimation and assessment of the prevalence of MS and its components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study was conducted with 174 children\/adolescents aged 6\u201317\u2009years with normal body weight (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200948), obesity (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200992) and overweight (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200934). Klotho concentration was significantly higher in the obese children [median 168.6\u2009pg\/ml (90.2 to 375.9)]) than in the overweight [131.3\u2009pg\/ml (78.0 to 313.0)] and normal-body-weight subjects [116.6\u2009pg\/ml (38.5 to 163.9)] (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0334) and was also significantly higher in insulin-resistant children than in insulin-sensitive children [185.3\u2009pg\/ml (102.1 to 398.2) vs 132.6\u2009pg\/ml (63.9 to 275.6),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0283]. FGF21 was elevated in patients with MS compared to the FGF21 levels in other subjects [136.2\u2009pg\/ml (86.5 to 239.9) vs 82.6\u2009pg\/ml (41.8 to 152.4),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0286]. The multivariable model showed that FGF19 was an independent predictor of IR after adjusting for pubertal stage and BMI Z-score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Klotho levels were associated with body weight status in children and adolescents. Moreover, Klotho, FGF19 and FGF21 concentrations correlated with IR status and\/or components of MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-020-02199-2","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:02:17Z","timestamp":1592269337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3690-6328","authenticated-orcid":false,"given":"Anna","family":"Socha-Banasiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Pacze\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Gaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"G\u0142owacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Kapka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Go\u0142\u0105bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Czkwianianc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"crossref","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766\u201381.","DOI":"10.1016\/S0140-6736(14)60460-8"},{"issue":"4","key":"2199_CR2","first-page":"641","volume":"70","author":"Z Ku\u0142aga","year":"2016","unstructured":"Ku\u0142aga Z, Grajda A, Gurzkowska B, Wojtylo MA, Gozdz M, Litwin MS. The prevalence of overweight and obesity among polish school-aged children and adolescents. Przegl Epidemiol. 2016;70(4):641\u201351.","journal-title":"Przegl Epidemiol"},{"issue":"6","key":"2199_CR3","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132(6):2169\u201380.","journal-title":"Gastroenterology"},{"issue":"6","key":"2199_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1203\/01.pdr.0000262638.48304.ef","volume":"61","author":"A Korner","year":"2007","unstructured":"Korner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New predictors of the metabolic syndrome in children-role of adipocytokines. Pediatric Res. 2007;61(6):640\u20135.","journal-title":"Pediatric Res"},{"issue":"10","key":"2199_CR5","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1210\/me.2015-1155","volume":"29","author":"F Zhang","year":"2015","unstructured":"Zhang F, Yu L, Lin X, Cheng P, He L, Li X, et al. Minireview: roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases. Mol Endocrinol. 2015;29(10):1400\u201313.","journal-title":"Mol Endocrinol"},{"key":"2199_CR6","doi-asserted-by":"publisher","unstructured":"Wang D, Zhu W, Li J, An C, Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS One. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0081190.","DOI":"10.1371\/journal.pone.0081190"},{"issue":"2","key":"2199_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","volume":"75","author":"K Dolegowska","year":"2019","unstructured":"Dolegowska K, Marchelek-Mysliwiec M, Nowosiad-Magda M, Slawinski M, Dolegowska B. FGF19 subfamily members: FGF19 and FGF21. J Physiol Biochem. 2019;75(2):229\u201340.","journal-title":"J Physiol Biochem"},{"issue":"19","key":"2199_CR8","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.3390\/ijms20194692","volume":"20","author":"\u00da Mart\u00ednez-Garza","year":"2019","unstructured":"Mart\u00ednez-Garza \u00da, Torres-Oteros D, Yarritu-Gallego A, Marrero PF, Haro D, Relat J. Fibroblast growth factor 21 and the adaptive response to nutritional challenges. Int J Mol Sci. 2019;20(19):4692.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2199_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1210\/er.2018-00134","volume":"39","author":"E Somm","year":"2018","unstructured":"Somm E, Jornayvaz FR. Fibroblast growth factor 15\/19: from basic functions to therapeutic perspectives. Endocr Rev. 2018;39(6):960\u201389.","journal-title":"Endocr Rev"},{"issue":"3","key":"2199_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","volume":"36","author":"J G\u00f3mez-Ambrosi","year":"2017","unstructured":"G\u00f3mez-Ambrosi J, Gallego-Escuredo JM, Catal\u00e1n V, Rodriguez A, Domingo P, Moncada R, et al. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. Clin Nutr. 2017;36(3):861\u20138.","journal-title":"Clin Nutr"},{"issue":"3","key":"2199_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.diabet.2016.12.003","volume":"43","author":"G Li","year":"2017","unstructured":"Li G, Yin J, Fu J, Li L, Grant SFA, Li C, et al. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: the BCAMS study. Diabetes Metab. 2017;43(3):253\u201360.","journal-title":"Diabetes Metab"},{"issue":"11\u201312","key":"2199_CR12","first-page":"1089","volume":"25","author":"M Wojcik","year":"2012","unstructured":"Wojcik M, Janus D, Dolezal-Oltarzewska K, Kalicka-Kasperczyk A, Poplawska K, Drozdz D, et al. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. J Pediatr Endocrinol Metab. 2012;25(11\u201312):1089\u201393.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"2199_CR13","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1210\/jc.2015-1800","volume":"100","author":"K Lim","year":"2015","unstructured":"Lim K, Groen A, Molostvov G, Lu T, Lilley KS, Snead D, et al. \u03b1-Klotho expression in human tissues. J Clin Endocrinol Metab. 2015;100(10):1308\u201318.","journal-title":"J Clin Endocrinol Metab"},{"key":"2199_CR14","doi-asserted-by":"publisher","unstructured":"Dalton GD, Xie J, An SW, Huang CL. New insights into the mechanism of action of soluble Klotho. Front Endocrinol. 2017. https:\/\/doi.org\/10.3389\/fendo.2017.00323.","DOI":"10.3389\/fendo.2017.00323"},{"issue":"11","key":"2199_CR15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.metabol.2016.08.004","volume":"65","author":"T Rubinek","year":"2016","unstructured":"Rubinek T, Shahmoon S, Shabtay-Orbach A, Ben Ami M, Levy-Shraga Y, Mazor-Aronovitch K, et al. Klotho response to treatment with growth hormone and the role of IGF-I as a mediator. Metabolism. 2016;65(11):1597\u2013604.","journal-title":"Metabolism"},{"issue":"6","key":"2199_CR16","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1096\/fj.10-167056","volume":"25","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Kato S, Akiyoshi J, Atfi A, Rozzaque MS. Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions. FASEB J. 2011;25(6):2031\u20139.","journal-title":"FASEB J"},{"issue":"9","key":"2199_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.nut.2013.02.005","volume":"29","author":"M Amitani","year":"2013","unstructured":"Amitani M, Asakawa A, Amitani H, Kaimoto K, Sameshima N, Koyama KI, et al. Plasma klotho levels decrease in both anorexia nervosa and obesity. Nutrition. 2013;29(9):1106\u20139.","journal-title":"Nutrition"},{"key":"2199_CR18","doi-asserted-by":"publisher","unstructured":"Amaro-Gahete FJ, De-la-O A, Jurado-Fasoli L, Espuch-Oliver A, de Haro T, Gutierrez A, et al. Body composition and S-Klotho plasma levels in middle-aged adults: a cross-sectional study. Rejuvenation Res. 2019. https:\/\/doi.org\/10.1089\/rej.2018.2092.","DOI":"10.1089\/rej.2018.2092"},{"issue":"5","key":"2199_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1515\/jpem-2017-0357","volume":"31","author":"JM Wojcicki","year":"2018","unstructured":"Wojcicki JM, Prather AA, Epel E, Wang D, Dubal DB. Cord blood klotho levels are inversely associated with leptin in healthy Latino neonates at risk for obesity. J Pediatr Endocrinol Metab. 2018;31(5):515\u201320.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2199_CR20","first-page":"22","volume-title":"Feeding and nutritional treatment of children and adolescents (in polish)","author":"A Horvath","year":"2017","unstructured":"Horvath A, Rachtan-Janicka J. Energy requirements. In: Szajewska H, Horvath A, editors. Feeding and nutritional treatment of children and adolescents (in polish). Krak\u00f3w: Medycyna Praktyczna; 2017. p. 22\u201331."},{"issue":"6","key":"2199_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00431-013-1954-2","volume":"172","author":"Z Ku\u0142aga","year":"2013","unstructured":"Ku\u0142aga Z, Grajda A, Gurzkowska B, G\u00f3\u017ad\u017a M, Wojty\u0142o M, Swi\u0105der A, et al. Polish 2012 growth references for preschool children. Eur J Pediatr. 2013;172(6):753\u201361.","journal-title":"Eur J Pediatr"},{"key":"2199_CR22","first-page":"119","volume":"12","author":"Z Ku\u0142aga","year":"2015","unstructured":"Ku\u0142aga Z, R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska A, Grajda A, Gurzkowska B, Wojty\u0142o M, G\u00f3\u017ad\u017a M, et al. Percentile charts for growth and nutritional status assessment in polish children and adolescents from birth to 18 year of age. Standrady Medyczne\/Pediatria. 2015;12:119\u201335.","journal-title":"Standrady Medyczne\/Pediatria"},{"key":"2199_CR23","first-page":"709","volume":"60","author":"MH Slaughter","year":"1988","unstructured":"Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, et al. Skin fold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709\u201323.","journal-title":"Hum Biol"},{"key":"2199_CR24","first-page":"22","volume":"1","author":"Z Ku\u0142aga","year":"2013","unstructured":"Ku\u0142aga Z, Grajda A, Gurzkowska B, G\u00f3\u017ad\u017a M, Wojty\u0142o M, \u015awi\u0105der A, et al. Centile charts for blood pressure assessment in children and adolescents aged 3-18 years. Standardy Medyczne\/Pediatria. 2013;1:22\u201330.","journal-title":"Standardy Medyczne\/Pediatria"},{"issue":"Suppl 2","key":"2199_CR25","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.2223\/JPED.301","volume":"77","author":"E Chipkevitch","year":"2001","unstructured":"Chipkevitch E. Clinical assessment of sexual maturation in adolescents. J Pediatr. 2001;77(Suppl 2):S135\u201342.","journal-title":"J Pediatr"},{"issue":"3","key":"2199_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4274\/jcrpe.v2i3.100","volume":"2","author":"S Kurto\u011flu","year":"2010","unstructured":"Kurto\u011flu S, Hatipo\u011flu N, Maz\u0131c\u0131o\u011flu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol. 2010;2(3):100\u20136.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2199_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F. The metabolic syndrome in children and adolescents \u2013 an IDF consensus report. Pediatr Diabetes. 2007;8:299\u2013306.","journal-title":"Pediatr Diabetes"},{"issue":"1\u20132","key":"2199_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2152\/jmi.61.28","volume":"61","author":"QR Jin","year":"2014","unstructured":"Jin QR, Bando Y, Miyawaki K, Shikama Y, Kosugi C, Aki N, et al. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects. J Med Investig. 2014;61(1\u20132):28\u201334.","journal-title":"J Med Investig"},{"issue":"1","key":"2199_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cen.12134","volume":"80","author":"Y Lee","year":"2014","unstructured":"Lee Y, Lim S, Hong ES, Kim JH, Moon MK, Chun EJ, et al. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clin Endocrinol. 2014;80(1):57\u201364.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2199_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627\u201335.","journal-title":"J Clin Invest"},{"key":"2199_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223\u201341.","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"2199_CR32","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018\u201327.","journal-title":"Endocrinology"},{"issue":"2","key":"2199_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774\u201381.","journal-title":"Endocrinology"},{"issue":"11","key":"2199_CR34","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes. 2010;59(11):2781\u20139.","journal-title":"Diabetes"},{"issue":"3","key":"2199_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.7570\/jomes.2017.26.3.204","volume":"26","author":"J Baek","year":"2017","unstructured":"Baek J, Nam HK, Rhie YJ, Lee KH. Serum FGF21 levels in obese Korean children and adolescents. J Obes Metab Syndr. 2017;26(3):204\u20139.","journal-title":"J Obes Metab Syndr"},{"issue":"6","key":"2199_CR36","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1210\/jc.2012-1221","volume":"97","author":"T Reinehr","year":"2012","unstructured":"Reinehr T, Woelfle J, Wunsch R, Roth CL. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab. 2012;97(6):2143\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"2199_CR37","doi-asserted-by":"publisher","unstructured":"Li H, Wu G, Fang Q, Zhang M, Hui X, Sheng B, et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-017-02677-9.","DOI":"10.1038\/s41467-017-02677-9"},{"issue":"1","key":"2199_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ijo.2014.76","volume":"39","author":"JM Gallego-Escuredo","year":"2015","unstructured":"Gallego-Escuredo JM, G\u00f3mez-Ambrosi J, Catalan V, Domingo P, Giralt M, Fr\u00fchbeck G, et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes. 2015;39(1):121\u20139.","journal-title":"Int J Obes"},{"issue":"2","key":"2199_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1194\/jlr.M027094","volume":"54","author":"X Wu","year":"2013","unstructured":"Wu X, Ge H, Baribault H, Gupte J, Weiszmann J, Lemon B, et al. Dual actions of fibroblast growth factor 19 on lipid metabolism. J Lipid Res. 2013;54(2):325\u201332.","journal-title":"J Lipid Res"},{"issue":"1","key":"2199_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","volume":"3","author":"G Marcelin","year":"2013","unstructured":"Marcelin G, Jo YH, Li X, Schwartz GJ, Zhang Y, Dun NJ, et al. Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism. Mol Metab. 2013;3(1):19\u201328.","journal-title":"Mol Metab"},{"issue":"2","key":"2199_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"MB Vos","year":"2017","unstructured":"Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the north American Society of Pediatric Gastroenterology, Hepatology and nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319\u201334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"2199_CR42","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/en.2005-1529","volume":"147","author":"Y Chihara","year":"2006","unstructured":"Chihara Y, Rakugi H, Ishikawa K, Ikushima M, Maekawa Y, Ohta J, et al. Klotho protein promotes adipocyte differentiation. Endocrinology. 2006;147(8):3835\u201342.","journal-title":"Endocrinology"},{"issue":"10","key":"2199_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrendo.2012.75","volume":"8","author":"MS Razzaque","year":"2012","unstructured":"Razzaque MS. The role of Klotho in energy metabolism. Nat Rev Endocrinol. 2012;8(10):579\u201387.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2199_CR44","first-page":"49","volume":"1790","author":"M Kuro-o","year":"2009","unstructured":"Kuro-o M. Klotho and aging. Biochim Biophys Acta. 2009;1790(10):49\u20131058.","journal-title":"Biochim Biophys Acta"},{"issue":"45","key":"2199_CR45","doi-asserted-by":"publisher","first-page":"38029","DOI":"10.1074\/jbc.M509039200","volume":"280","author":"M Yamamoto","year":"2005","unstructured":"Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem. 2005;280(45):38029\u201334.","journal-title":"J Biol Chem"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02199-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-020-02199-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02199-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T19:20:39Z","timestamp":1623784839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-02199-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-02199-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23889\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Bioethics Committee of the Polish Mothers Memorial Hospital-Research Institute (PMMH-RI 39\/2015). Parents and children \u226516\u2009years old provided written informed consent before participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}